Hepion Pharmaceuticals, Inc. (HEPA)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-310.3%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0 | $0 | $0 | $0 | — | — | — | — |
| Operating Income | -$4.16M | -$19.35M | -$48.45M | -$45.49M | -$30.40M | -$20.15M | -$7.77M | -$14.59M | -$20.65M | -$20.81M |
| Net Income | -$8.28M | -$13.19M | -$48.93M | -$42.20M | -$32.72M | -$20.35M | -$7.04M | -$9.45M | -$14.89M | -$17.00M |
| EPS (Diluted) | $-0.88 | $-107.35 | $-616.07 | $-11.90 | $-0.47 | $-2.10 | $-5.95 | $-97.35 | $-2.04 | $-0.63 |
| Total Assets | $3.07M | $1.61M | $18.09M | $60.24M | $103.55M | $48.65M | $20.61M | $8.19M | $11.25M | $13.11M |
| Total Liabilities | $402.4K | $3.48M | $10.81M | $10.39M | $10.56M | $8.12M | $4.99M | $6.21M | $7.55M | $11.79M |
| Shareholders' Equity | $2.67M | -$1.86M | $7.28M | $49.86M | $93.00M | $40.52M | $15.62M | $1.72M | $3.70M | $1.32M |
| Cash & Equivalents | — | — | — | — | — | — | $13.92M | $2.83M | $5.95M | $7.40M |
| Operating Cash Flow | -$3.27M | -$18.22M | -$40.89M | -$34.96M | -$31.22M | -$16.17M | -$7.57M | -$15.65M | -$19.17M | -$16.56M |
| Capital Expenditures | — | — | $14.3K | $16.3K | $130.4K | $88.0K | $51.5K | — | $14.7K | $6.6K |
| Shares Outstanding | 11.62M | 139.2K | 96.4K | 3.81M | 76.23M | 32.03M | 3.76M | 247.0K | 9.79M | 32.23M |